Academic Rank:
Clinical Instructor, UBC
Hematopathologist, Royal Columbian Hospital
Affiliation(s):
Royal Columbian Hospital
Short Bio:

Dr. Razavi is a Hematopathologist at Fraser Health Authority, rotating between the Royal Columbian and Surrey Memorial Hospitals. Immigrating to Canada in 1986, he obtained his undergraduate and graduate degrees from the University of Toronto and University of Western Ontario. Following his PhD training in Pharmacology and Critical Care Medicine, he received further advanced research training at Texas A&M University by completing a post-doctoral fellowship in physiology. Changing career tracks he enrolled in Medical school at the University of Ottawa followed by Anesthesia residency at UBC. His Anesthesiology residency rotations in the blood bank introduced a whole new field where he then commenced a residency program in Hematopathology. He is a board certified fellow of the Royal College of Physicians and Surgeons of Canada (RCPSC). His professional interests include all areas of benign and malignant hematology, transfusion medicine, coagulation disorders and hemoglobinopathy among others. He is actively involved in resident teaching and resident lead research projects.

Academic background

  • Fellow, Royal College of Physicians of Canada (FRCPC), Hematological Pathology. 2017
  • Board-certified, Hematological Pathology, Royal College of Physicians and Surgeons of Canada (RCPSC). 2017
  • Licentiate of the Medical Council of Canada (LMCC). 2016
  • Doctor of medicine, UOttawa, (2010)
  • Post doctoral fellowship, Physiology and Translational medicine, Texsas A&M (2006)
  • Doctor of Philosophy, Pharmacology, UWO (2003)
  • Master of Science, Pharmacology and Toxicology, UofT (1998)
  • Bachelor of Science, Pharmacology and Toxicology, UofT (1995)

Publications

Selected Publications:

  • A case of bony lytic lesions in a patient with Gaucher disease. Clin Case Rep. 2019;00:1–4.
  • Unusual presentation of Burkitt-like lymphoma with 11q aberration in an elderly patient. Blood 2019 133:381
  • Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am J Physiol Lung Cell Mol Physiol. 290(6):L1164-72
  • Pulmonary Oxidant Stress in Murine Sepsis is Due to Inflammatory Cell Inducible Nitric Oxide. Crit Care Med. 33(6):1333-9.
  • Modulation of Apoptosis by Nitric Oxide: Implications in Myocardial Ischemia and Heart Failure. Pharmacol Ther. 106(2):147-62.
  • Pulmonary Neutrophil Infiltration in Murine Sepsis: Role of Inducible Nitric Oxide synthase. Am J Respir Crit Care Med. 170(3):227-33.
  • Effects of nebulized diethylenetetraamine-NONOate in a mouse model of acute Pseudomonas aeruginosa pneumonia. Chest. 122(6):2127-36.
  • Role of inducible nitric oxide synthase in pulmonary microvascular protein leak in murine sepsis. Am J Respir Crit Care Med. 165(12):1634-9.
  • Effects of inhaled nitric oxide in a mouse model of sepsis-induced acute lung injury. Crit Care Med. 30(4):868-73.